Skip to main content
SpringerLink
Log in

In vitro activity of the new quinolone BAY y 3118 against anaerobic bacteria

  • New Antimicrobial Agent
  • Published:
European Journal of Clinical Microbiology and Infectious Diseases Aims and scope Submit manuscript

Abstract

The in vitro activity of BAY y 3118 against anaerobic cocci,Propionibacterium acnes, Clostridium perfringens, Clostridium difficile, Bacteroides fragilis, otherBacteroides spp. and fusobacteria was determined by an agar dilution method. This activity was compared with that of ciprofloxacin, ofloxacin, piperacillin, cefoxitin, imipenem, clindamycin and metronidazole. BAY y 3118, imipenem, clindamycin and metronidazole were the most active agents tested. The in vitro activity of BAY y 3118 against anaerobic bacteria was superior to that of ciprofloxacin and ofloxacin.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Holdeman LV, Cato EP, Moore WEC Anaerobe laboratory manual, Virginia Polytechnic Institute and State University, Blacksburg, VA, 1977, p. 1–156.

    Google Scholar 

  2. Dornbusch K, Nord CE, Olsson-Liljequist B Antibiotic susceptibility of anaerobic bacteria with special reference toBacteroides fragilis. Scandinavian Journal of Infectious Diseases 1979, 19: 17–25.

    PubMed  Google Scholar 

  3. National Committee for Clinical Laboratory Standards Methods for antimicrobial susceptibility testing of anaerobic bacteria, 2nd ed. NCCLS Document M11-A2. National Committee for Clinical Standards, Villanova, PA, 1990.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Microbiology, Huddinge University Hospital, Karolinska Institute, S-141 86, Huddinge, Sweden

    C. E. Nord

  2. National Bacteriological Laboratory, S-105 21, Stockholm

    C. E. Nord, A. Lindmark & I. Persson

Authors
  1. C. E. Nord
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. A. Lindmark
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. I. Persson
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Nord, C.E., Lindmark, A. & Persson, I. In vitro activity of the new quinolone BAY y 3118 against anaerobic bacteria. Eur. J. Clin. Microbiol. Infect. Dis. 12, 640–642 (1993). https://doi.org/10.1007/BF01973648

Download citation

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01973648

Keywords

Search

Navigation